About Vicinitas
Vicinitas is a company based in San Francisco (United States) founded in 2022 by Dan Nomura.. Vicinitas has raised $130 million across 2 funding rounds from investors including Andreessen Horowitz, Deerfield and Droia Ventures. Vicinitas offers products and services including DUBTAC Platform. Vicinitas operates in a competitive market with competitors including Accutar Biotechnology, Plexium, Lycia Therapeutics, Photys Therapeutics and Uvic Steratics, among others.
- Headquarter San Francisco, United States
- Founders Dan Nomura
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Vicinitas Therapeutics.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$130 M (USD)
in 2 rounds
-
Latest Funding Round
$65 M (USD), Series A
Jul 29, 2022
-
Investors
Andreessen Horowitz
& 5 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Vicinitas
Vicinitas offers a comprehensive portfolio of products and services, including DUBTAC Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform restores degraded proteins to treat diseases effectively
Funding Insights of Vicinitas
Vicinitas has successfully raised a total of $130M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $65 million completed in July 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $65.0M
-
First Round
First Round
(28 Jul 2022)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2022 | Amount | Series A - Vicinitas | Valuation |
investors |
|
| Jul, 2022 | Amount | Series A - Vicinitas | Valuation | a16z , Deerfield |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Vicinitas
Vicinitas has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Andreessen Horowitz, Deerfield and Droia Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments in technology sectors are handled by Andreessen Horowitz.
|
Founded Year | Domain | Location | |
|
Healthcare ecosystem is supported through investment and innovation by Deerfield.
|
Founded Year | Domain | Location | |
|
Droia Ventures is focused on investing in drug development companies.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Vicinitas
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Vicinitas
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Vicinitas Comparisons
Competitors of Vicinitas
Vicinitas operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Accutar Biotechnology, Plexium, Lycia Therapeutics, Photys Therapeutics and Uvic Steratics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
AI-assisted tools for drug discovery are developed.
|
|
| domain | founded_year | HQ Location |
Integrated chemistry service provider
|
|
| domain | founded_year | HQ Location |
Protein degradation drugs are developed for cancer and autoimmune diseases.
|
|
| domain | founded_year | HQ Location |
Protein-based small molecules are developed to treat human diseases.
|
|
| domain | founded_year | HQ Location |
Anti-cancer drugs are developed via Proteolysis Targeting Chimera technology.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Vicinitas
Frequently Asked Questions about Vicinitas
When was Vicinitas founded?
Vicinitas was founded in 2022.
Where is Vicinitas located?
Vicinitas is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Is Vicinitas a funded company?
Vicinitas is a funded company, having raised a total of $130M across 2 funding rounds to date. The company's 1st funding round was a Series A of $65M, raised on Jul 28, 2022.
What does Vicinitas do?
Vicinitas was founded in 2022 in San Francisco, United States, within the biotechnology sector. Therapeutics targeting cancer and monogenic diseases are developed through Deubiquituinase Targeting Chimeras (DUBTACs). These stabilizers prevent the degradation of specific proteins, thereby restoring their levels. Operations focus on protein stabilization mechanisms to address genetic disorders and oncology applications.
Who are the top competitors of Vicinitas?
Vicinitas's top competitors include Plexium, Photys Therapeutics and Uvic Steratics.
What products or services does Vicinitas offer?
Vicinitas offers DUBTAC Platform.
Who are Vicinitas's investors?
Vicinitas has 6 investors. Key investors include Andreessen Horowitz, Deerfield, Droia Ventures, Google Ventures, and The Mark Foundation for Cancer Research.